These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
434 related items for PubMed ID: 26446603
1. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing. Walker A, Skibbe K, Steinmann E, Pfaender S, Kuntzen T, Megger DA, Groten S, Sitek B, Lauer GM, Kim AY, Pietschmann T, Allen TM, Timm J. J Virol; 2016 Jan 01; 90(1):33-42. PubMed ID: 26446603 [Abstract] [Full Text] [Related]
2. Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope. Ruhl M, Chhatwal P, Strathmann H, Kuntzen T, Bankwitz D, Skibbe K, Walker A, Heinemann FM, Horn PA, Allen TM, Hoffmann D, Pietschmann T, Timm J. J Virol; 2012 Jan 01; 86(2):991-1000. PubMed ID: 22072759 [Abstract] [Full Text] [Related]
3. CD8 epitope escape and reversion in acute HCV infection. Timm J, Lauer GM, Kavanagh DG, Sheridan I, Kim AY, Lucas M, Pillay T, Ouchi K, Reyor LL, Schulze zur Wiesch J, Gandhi RT, Chung RT, Bhardwaj N, Klenerman P, Walker BD, Allen TM. J Exp Med; 2004 Dec 20; 200(12):1593-604. PubMed ID: 15611288 [Abstract] [Full Text] [Related]
4. Differential escape of HCV from CD8+ T cell selection pressure between China and Germany depends on the presenting HLA class I molecule. Xia Y, Pan W, Ke X, Skibbe K, Walker A, Hoffmann D, Lu Y, Yang X, Feng X, Tong Q, Timm J, Yang D. J Viral Hepat; 2019 Jan 20; 26(1):73-82. PubMed ID: 30260541 [Abstract] [Full Text] [Related]
5. Impact of sequence variation in a dominant HLA-A*02-restricted epitope in hepatitis C virus on priming and cross-reactivity of CD8+ T cells. Ziegler S, Skibbe K, Walker A, Ke X, Heinemann FM, Heinold A, Mok JY, van Esch WJ, Yang D, Wölfl M, Timm J. J Virol; 2014 Oct 20; 88(19):11080-90. PubMed ID: 25008925 [Abstract] [Full Text] [Related]
6. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073. Fytili P, Dalekos GN, Schlaphoff V, Suneetha PV, Sarrazin C, Zauner W, Zachou K, Berg T, Manns MP, Klade CS, Cornberg M, Wedemeyer H. Vaccine; 2008 Jul 23; 26(31):3818-26. PubMed ID: 18582999 [Abstract] [Full Text] [Related]
13. CD8+ T-cell response promotes evolution of hepatitis C virus nonstructural proteins. Ruhl M, Knuschke T, Schewior K, Glavinic L, Neumann-Haefelin C, Chang DI, Klein M, Heinemann FM, Tenckhoff H, Wiese M, Horn PA, Viazov S, Spengler U, Roggendorf M, Scherbaum N, Nattermann J, Hoffmann D, Timm J, East German HCV Study Group. Gastroenterology; 2011 Jun 23; 140(7):2064-73. PubMed ID: 21376049 [Abstract] [Full Text] [Related]
14. Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population level. Neumann-Haefelin C, Frick DN, Wang JJ, Pybus OG, Salloum S, Narula GS, Eckart A, Biezynski A, Eiermann T, Klenerman P, Viazov S, Roggendorf M, Thimme R, Reiser M, Timm J. J Virol; 2008 Apr 23; 82(7):3438-51. PubMed ID: 18216107 [Abstract] [Full Text] [Related]
15. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C. López-Labrador FX, He XS, Berenguer M, Cheung RC, González-Candelas F, Wright TL, Greenberg HB. J Med Virol; 2004 Apr 23; 72(4):575-85. PubMed ID: 14981760 [Abstract] [Full Text] [Related]